The National Cancer Institute is offering a grant for establishing research teams to form the Small-Cell Lung Cancer (SCLC) Consortium. The grant aims to enhance SCLC therapeutics by exploring molecular vulnerabilities for developing targeted agent combinations and understanding clinical resistance to therapies. Research teams will collaborate with a central SCLC Coordinating Center to utilize state-of-the-art tools and omic profiles to identify effective therapeutic strategies for SCLC progression and resistance. An additional focus is on prevention and early detection of SCLC. Applications are open until March 11, 2022.
Opportunity ID: 320095
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-361 |
| Funding Opportunity Title: | Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 29, 2019 |
| Last Updated Date: | Aug 29, 2019 |
| Original Closing Date for Applications: | Mar 11, 2022 |
| Current Closing Date for Applications: | Mar 11, 2022 |
| Archive Date: | Apr 16, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $450,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses City or township governments State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Private institutions of higher education County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve SCLC therapeutics, focusing on understanding how the molecular vulnerabilities of this cancer could be used to develop targeted agent combinations; and/or, 2) to gain a better understanding of the rapid development of clinical resistance to drug and radiation therapy. This FOA focuses on two of the five research priorities identified in the National Cancer Institute’s 2014 Scientific Framework for Small Cell Lung Cancer (SCLC). Additional priorities of the Framework are stated in this FOA, as studies are expected to use or develop state-of-the-art research tools and omic profiles to identify therapeutic strategies that are relevant to human SCLC disease progression and resistance. The research supported by this FOA will be performed by individual research teams who are expected to collaborate with one another and with a central SCLC Coordinating Center. A third component of the SCLC Consortium focuses on prevention and early detection of SCLC. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-361.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 320095 Full Announcement-PAR-19-361 -> PAR-19-361-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259476 | Oct 12, 2019 | Jan 24, 2022 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254328 | Oct 12, 2019 | May 24, 2020 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270413 | Nov 18, 2021 | Mar 11, 2022 | View |
Package 1
Mandatory forms
320095 RR_SF424_2_0-2.0.pdf
320095 PHS398_CoverPageSupplement_5_0-5.0.pdf
320095 RR_OtherProjectInfo_1_4-1.4.pdf
320095 PerformanceSite_2_0-2.0.pdf
320095 RR_KeyPersonExpanded_2_0-2.0.pdf
320095 PHS398_ResearchPlan_4_0-4.0.pdf
320095 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320095 RR_Budget_1_4-1.4.pdf
320095 RR_SubawardBudget30_1_4-1.4.pdf
320095 PHS398_ModularBudget_1_2-1.2.pdf
320095 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
320095 RR_SF424_2_0-2.0.pdf
320095 PHS398_CoverPageSupplement_4_0-4.0.pdf
320095 RR_OtherProjectInfo_1_4-1.4.pdf
320095 PerformanceSite_2_0-2.0.pdf
320095 RR_KeyPersonExpanded_2_0-2.0.pdf
320095 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320095 RR_Budget_1_4-1.4.pdf
320095 RR_SubawardBudget30_1_4-1.4.pdf
320095 PHS398_ModularBudget_1_2-1.2.pdf
320095 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
320095 RR_SF424_5_0-5.0.pdf
320095 PHS398_CoverPageSupplement_5_0-5.0.pdf
320095 RR_OtherProjectInfo_1_4-1.4.pdf
320095 PerformanceSite_4_0-4.0.pdf
320095 RR_KeyPersonExpanded_4_0-4.0.pdf
320095 PHS398_ResearchPlan_4_0-4.0.pdf
320095 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
320095 RR_Budget_3_0-3.0.pdf
320095 RR_SubawardBudget30_3_0-3.0.pdf
320095 PHS398_ModularBudget_1_2-1.2.pdf
320095 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
